RJ
R. Jacob Vogelstein
OtherActiveCo-Founder and Managing Partner at Catalio Capital Management
15
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for R. Jacob Vogelstein.
Investment Thesis & Strategy
R. Jacob Vogelstein, as a Managing Partner at Catalio Capital Management, invests in various stages of AI/ML, biotech, diagnostics, drug delivery, and medical device companies. They seek to partner with companies that are developing groundbreaking technologies in the healthcare space.
Investment Activity
Deals per year over the last 6 years
2
20152
20163
20173
20181
20191
2020Portfolio Companies
Selected investments from their portfolio of 15 companies
V
Volastra Therapeutics
Biotech · Series A, 2020
F
Faze Medicines
Biotech · Series B, 2019
I
Immunai
Biotech · Series B, 2018
e
eNeura Therapeutics
Healthcare · Seed, 2018
A
ATAI Life Sciences
Biotech · Series B, 2018
S
Sensei Biotherapeutics
Biotech · Series A, 2017
P
Paige
Healthcare · Series B, 2017
R
Recursion Pharmaceuticals
Biotech · Series C+, 2017
F
Freenome
Biotech · Series B, 2016
C
Cambrian Biopharma
Biotech · Growth, 2016
G
Glympse Bio
Biotech · Series B, 2015
E
EGenesis
Biotech · Series B, 2015
Frequently Asked Questions
R. Jacob Vogelstein focuses on Seed stage investments.
Related Investors
Gopal Rajaraman
Bethesda, United States · 75 deals
BroadOak Capital Partners
Bethesda, United States · 11 deals
Chesapeake Partners Management
Bethesda, United States · 2 deals
England & Company
Bethesda, United States · 0 deals
Chessiecap
Bethesda, United States · 0 deals
Capital Business Collective
Bethesda, United States · 0 deals